HopeStage
Back to all studies
CompletedNCT05470465

How antidepressants and oxycodone together affect breathing

About this titleRead the official source — NCT05470465
Medication studyAges 18–50United StatesDepression
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 50 years.

Listed locations
West BendSee all locations and recruitment
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: September 1, 2022
Recruitment status
Completed
Enrollment listed in the registry
27
Sponsor
Food and Drug Administration (FDA)
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Locations
United States
Age range
From 18 Years to 50 Years
Official registry ID
NCT05470465
Official title
Show the full official title

Clinical Study to Investigate the Effect of Administration of Selective Serotonin Reuptake Inhibitors (SSRIs) and an Opioid on Ventilation

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

West Bend

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Food and Drug Administration (FDA).

Did this study involve medication?

Yes. The study involved medication, including Placebo and Oxycodone, Paroxetine and Oxycodone and Escitalopram and Oxycodone.

Who was this study for?

Listed age limits: 18 years to 50 years.

Want to explore more studies?

Explore studies